Tyrosine Kinase
- IGFBR(1)
- Bcr-Abl(61)
- Ack1(2)
- Axl(6)
- ALK(53)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(30)
- c-Kit(54)
- c-MET(71)
- c-RET(1)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(201)
- EphB4(1)
- FAK(32)
- FGFR(83)
- FLT3(83)
- HER2(15)
- IGF1R(25)
- Insulin Receptor(36)
- IRAK(23)
- ITK(9)
- Lck(1)
- LRRK2(20)
- PDGFR(97)
- PTKs/RTKs(3)
- Pyk2(6)
- ROR(35)
- Spleen Tyrosine Kinase (Syk)(31)
- Src(88)
- Tie-2 (3)
- Trk(33)
- VEGFR(167)
- Discoidin Domain Receptor(14)
- DYRK(23)
- Ephrin Receptor(9)
- ROS(14)
- RET(26)
- TAM Receptor(27)
- Cat.No. Product Name Information
-
GN10784
Rhoifolin
-
GN10737
Tanshinone IIA
-
GN10633
Scutellarein
-
GN10603
Sennoside B
-
GN10540
Fumalic acid
-
GN10527
Formononetin
-
GN10503
Piceatannol
-
GN10497
Kaempferitrin
-
GN10336
Daphnetin
-
GN10327
Chrysophanol
-
GN10325
Nobiletin
-
GN10156
Ginsenoside Rb1
-
GC11496
TLQP 21
-
GC12656
ZM323881
A potent and selective VEGFR2 inhibitor
-
GC13102
XL228
A tyrosine kinase inhibitor
-
GC11876
Vandetanib hydrochloride
A multi-kinase inhibitor
-
GC10719
Toceranib
A multi-targeted receptor tyrosine kinase inhibitor
-
GC11622
TG 100801
-
GC15307
SU5416
A tyrosine kinase inhibitor
-
GC14315
SU14813 maleate
A dual VEGFR and PDGFR family kinase inhibitor
-
GC11790
SU14813 double bond Z
Tyrosine kinase inhibitor
-
GC14733
SU14813
A dual VEGFR and PDGFR family kinase inhibitor
-
GC14660
SU 5402
An inhibitor of VEGFR2, FGFR1, and PDGFRβ
-
GC12877
SR3335
A selective inverse agonist of RORα
-
GC16392
SR1078
A selective RORα/RORγ agonist
-
GC11455
Silvestrol
-
GC12064
SB1317
A multi-kinase inhibitor
-
GC14534
Regorafenib monohydrate
A multi-kinase inhibitor
-
GC14606
Regorafenib hydrochloride
A multi-kinase inhibitor
-
GC12857
R1530
A multi-kinase inhibitor
-
GC10499
PRT062607 Hydrochloride
-
GC15164
PND-1186
A potent FAK inhibitor
-
GC15733
PF-04217903 methanesulfonate
A c-Met inhibitor
-
GC16028
NVP-BGJ398 phosphate
-
GC14237
Nilotinib monohydrochloride monohydrate
A Bcr-Abl inhibitor
-
GC13012
Motesanib
-
GC13140
MK-8033
-
GC13424
LY2874455
A pan-FGFR inhibitor
-
GC11057
LY2801653
A MET kinase inhibitor
-
GC10809
LRRK2-IN-1
A selective LRRK2 inhibitor
-
GC14931
LDN193189 Hydrochloride
An inhibitor of BMP receptors ALK1, ALK2, ALK3, and ALK6
-
GC17452
LDK378 dihydrochloride
-
GC13117
Lck Inhibitor
A selective inhibitor of lymphocyte-specific protein tyrosine kinase
-
GC10222
KX2-391 dihydrochloride
A Src kinase inhibitor
-
GC10626
KU14R
-
GC13264
Ki20227
A c-Fms kinase inhibitor
-
GC16869
Ixabepilone
A broad-spectrum anticancer agent
-
GC12167
ITK inhibitor
Potent ITK inhibitor
-
GC15999
IRAK-1-4 Inhibitor I
A benzimidazole
-
GC17371
IRAK inhibitor 6
An IRAK4 inhibitor
-
GC16264
IRAK inhibitor 4
-
GC11103
IRAK inhibitor 3
-
GC12651
IRAK inhibitor 2
-
GC17158
IRAK inhibitor 1
An IRAK4 inhibitor
-
GC15263
Imatinib hydrochloride
V-Abl/c-Kit/PDGFR inhibitor
-
GC16244
Icotinib Hydrochloride
An EGFR inhibitor
-
GC14295
Gefitinib hydrochloride
An EGFR inhibitor
-
GC10627
Erlotinib
An EGFR tyrosine kinase inhibitor
-
GC10466
EMD-1214063
EMD-1214063 (Tepotinib, MSC2156119J) is a novel potent and highly selective reversible, ATP-competitive small molecule c-Met inhibitor .
-
GC12149
E-3810
-
GC11171
DCC-2618
A dual inhibitor of c-Kit and c-MET
-
GC14695
CO-1686 (AVL-301)
A selective inhibitor of mutant EGFR
-
GC14650
CGP60474
A CDK inhibitor
-
GC12087
Canertinib dihydrochloride
A pan-ErbB tyrosine kinase inhibitor
-
GC11063
BMX-IN-1
A selective BMX and BTK inhibitor
-
GC13873
BMS-690514
-
GC10606
BMS-599626 Hydrochloride
-
GC10455
BMS-509744
-
GC10087
BIBX 1382
An EGFR inhibitor
-
GC12136
BAY 61-3606 dihydrochloride
-
GC16389
BAY 61-3606
A Syk inhibitor
-
GC17045
AXL1717
A potent and selective inhibitor of IGF-1R
-
GC10914
AST 487
A multi-kinase inhibitor
-
GC14446
ASP3026
An ALK inhibitor
-
GC11134
ALW-II-41-27
A multi-kinase inhibitor
-
GC17376
ALK inhibitor 2
An inhibitor of TSSK2
-
GC16228
AIM-100
An ACK1/TNK2 inhibitor
-
GC10707
Afatinib dimaleate
An inhibitor of EGFR and ErbB2
-
GC16391
Amuvatinib (MP-470, HPK 56)
A multi-targeted RTK inhibitor
-
GC18074
PF-03814735
An inhibitor of Aurora A and B kinases
-
GC14592
KW 2449
A multi-kinase inhibitor
-
GC10638
AT9283
A broad spectrum kinase inhibitor
-
GC15217
Danusertib (PHA-739358)
A pan-Aurora kinase and Abl inhibitor
-
GC16519
ENMD-2076
A multi-kinase inhibitor
-
GC12145
ENMD-2076 L-(+)-Tartaric acid
-
GC15589
WHI-P154
A JAK3 inhibitor
-
GC13848
LY2784544
Potent inhibitor of JAK2
-
GC10035
TG101209
An inhibitor of JAK2, FLT3, RET, and JAK3
-
GC16008
CUDC-101
A multi-target inhibitor of HDACs, EGFR, and HER2
-
GC16327
Pazopanib (GW-786034)
A multi-kinase inhibitor
-
GC14729
(R)-Crizotinib
A c-MET and ALK receptor tyrosine kinase inhibitor
-
GC15568
Dasatinib (BMS-354825)
An inhibitor of Abl and Src
-
GC10055
BGJ398
An FGFR inhibitor
-
GC17369
Sorafenib
A multi-kinase inhibitor
-
GC15983
PD 153035 hydrochloride
A highly potent EGFR inhibitor
-
GC12837
Compound 56
A potent EGFR inhibitor
-
GC15299
Staurosporine(CGP 41251)
A potent inhibitor of protein kinase C
-
GC26063
WAY-340935
WAY-340935 (VEGFR2-IN-2) can inhibit the function of VEGFR2 and the anti-proliferative activity against the H460 cell line is produced partly by interaction of VEGFR protein.
-
GC26021
UNC2025 HCl
UNC2025 HCl is a potent and orally bioavailable dual MER/FLT3 inhibitor with IC50 of 0.74 nM and 0.8 nM, respectively, about 20-fold selectivity over Axl and Tyro3.
-
GC26001
TPX-0046